指南与共识主动脉疾病

肾下腹主动脉瘤腔内修复术后CTA与彩超监测比较:费用影响与国际指南差异

Editor's Choice - A Comparison of Computed Tomography Angiography and Colour Duplex Ultrasound Surveillance Post Infrarenal Endovascular Aortic Aneurysm Repair: Financial Implications and Impact of Different International Surveillance Guidelines.
指南 / 共识 · Eur J Vasc Endovasc Surg · 2021-06-14

本研究比较彩超与CTA检测腹主动脉瘤腔内修复术后瘤囊异常的一致性,并基于289例活跃监测患者估算四种国际指南监测方案五年费用。彩超与CTA的kappa系数为0.68,NICE的CTA方案费用最高,对比剂相关急性肾损伤是费用差异的主要驱动因素。

要点

  • 彩超与CTA检测瘤囊异常的一致性中等(kappa 0.68)。
  • NICE的CTA监测方案五年费用最高,远超SVS、ESVS及本地方案。
  • 对比剂相关急性肾损伤而非直接影像费用是监测费用差异的主要来源。

核心结论

  • 联合CTA与彩超的监测方案,将CTA保留用于早期封闭评估和确认目的,可在不损害瘤囊异常检出的前提下提供经济的方法。
  • 对比剂相关急性肾损伤而非直接影像费用是监测费用估算差异的最大来源。

研究设计与样本

  • 单中心研究,纳入289例活跃监测的肾下EVAR患者,比较彩超与CTA检测显著瘤囊异常的一致性。
  • 将已发表指南外推为监测方案,估算假设五年监测期的费用,并纳入内漏发生率、对比剂相关急性肾损伤及超额住院床日的已发表范围。

主要发现

  • 彩超与CTA检测瘤囊异常的kappa系数为0.68。
  • 289例活跃EVAR患者五年监测最高费用估算:SVS方案£272 359,ESVS方案£230 708,NICE方案£643 802,本地方案£266 777,即每患者£1 270、£1 076、£3 003、£1 244。
  • 内漏发生率差异导致费用增加1.1至1.4倍。
  • 急性肾损伤发生率差异导致费用增加3.3至6.2倍。

临床怎么用

  • 可采用联合CTA与彩超的EVAR监测方案,CTA用于早期封闭评估和确认目的,以兼顾检出效果与费用。
  • 在制定监测策略时需重视对比剂相关急性肾损伤对总体费用的影响,而不仅关注影像检查直接成本。

局限性

  • 单中心研究,外推性有限。
  • 费用估算基于已发表的发生率范围进行敏感性分析,非实际观测数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Use of colour duplex ultrasound (CDUS) and computed tomography angiography (CTA) for infrarenal endovascular aortic aneurysm repair (EVAR) surveillance differs in internationally published guidelines. This study aimed firstly to compare CDUS detection of significant sac abnormalities with CTA. Secondly, a sensitivity analysis was conducted to compare financial estimates of the, predominantly CDUS based, local and Society of Vascular Surgery (SVS) protocols, the risk stratified European Society of Vascular Surgery (ESVS) protocol, and the CTA based National Institute of Health and Care Excellence (NICE) protocol. METHODS: Agreement between CDUS and CTA was assessed for detection of significant sac abnormalities. Surveillance protocols were extrapolated from published guidelines and applied to infrarenal EVAR patients active on local surveillance at a large, single centre. Surveillance intensity was dependent on presence of endoleak and subsequent risk of treatment failure in accordance with surveillance recommendations. Estimates for each surveillance protocol were inclusive of a range of published incidences of endoleak, contrast associated acute kidney injury (AKI), and excess hospital bed days, and estimated for a hypothetical five year surveillance period. RESULTS: The kappa coefficient between CDUS and CTA for detecting sac abnormalities was 0.68. Maximum five year surveillance cost estimates for the 289 active EVAR patients were £272 359 for SVS, £230 708 for ESVS, £643 802 for NICE, and £266 777 for local protocols, or £1 270, £1 076, £3 003, and £1 244 per patient. Differences in endoleak incidence accounted for a 1.1 to 1.4 fold increase in costs. AKI incidence accounted for a 3.3 to 6.2 fold increase in costs. CONCLUSION: A combined CTA and CDUS EVAR surveillance protocol, with CTA reserved for early seal assessment and confirmatory purposes, provides an economical approach without compromising detection of sac abnormalities. AKI, as opposed to direct imaging costs, accounted for the largest differences in surveillance cost estimates.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Smith L, Thomas N, Arnold A, et al. Editor's Choice - A Comparison of Computed Tomography Angiography and Colour Duplex Ultrasound Surveillance Post Infrarenal Endovascular Aortic Aneurysm Repair: Financial Implications and Impact of Different International Surveillance Guidelines. Eur J Vasc Endovasc Surg. 2021. PMID: 34140226. doi:10.1016/j.ejvs.2021.04.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。